Walleye Capital’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Walleye Capital's WST Position: Q3 2026 in Review
Walleye Capital opened a new position in West Pharmaceutical (WST) in Q3 2026: 8,521 shares worth $3.16M. The stake represents ﹤0.01% of the portfolio and ranks #2368 among its holdings. This is a return to the name: Walleye Capital previously reported a position in WST as recently as Q4 2025.
Walleye Capital first reported a position in WST in Q2 2022 and has held it in 13 quarters since. The position peaked at $37M in Q4 2025. 873 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Walleye Capital held 8,521 shares of West Pharmaceutical worth $3.16M as of Q3 2026.
- West Pharmaceutical was a new Walleye Capital position in Q3 2026.
- West Pharmaceutical made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2368 holding.
- Walleye Capital first reported a position in West Pharmaceutical in Q2 2022 and has held it in 13 quarters since.
- Walleye Capital's West Pharmaceutical position peaked at $37M in Q4 2025.
- 873 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.